Clinical Trial Update: Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Yttrium-90 Zevalin with Z-CHOP chemotherapy for stage II-IV Diffuse large B-cell lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: Chulalongkorn University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: TERMINATED